CytomX Therapeutics Inc (CTMX) Annual Income Statement (USD)
CTMX Quarterly Financials (USD)
Frequently Asked Questions About CytomX Therapeutics Inc (CTMX) Stock
CytomX Therapeutics Inc's (CTMX) last reported annual revenue was USD 138.10 Million.
CytomX Therapeutics Inc's (CTMX) annual revenue growth rate based on the revenue reported in the past 5 years is : 19.16%
CytomX Therapeutics Inc's(CTMX) is profitable as of its last reported annual financials.
The net profit margin for CytomX Therapeutics Inc's(CTMX) from its laster reported year is 23.08%
The return on equity (ROE) for CytomX Therapeutics Inc's(CTMX) from its last reported annual financials is : -5475.03%
The return on assets (ROA) for CytomX Therapeutics Inc's(CTMX) from its last reported annual financials is : 9.69%
The return on invested capital (ROIC) for CytomX Therapeutics Inc's(CTMX) from its last reported annual financials is : -103.42%
The Debt to Equity ratio for CytomX Therapeutics Inc's(CTMX) from its last reported annual financials is : 0.00%
The dividend yield for CytomX Therapeutics Inc's(CTMX) from its laster reported year is 0.00%
CytomX Therapeutics Inc's(CTMX) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for CTMX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
